These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6852982)

  • 1. Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.
    Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
    Int J Cancer; 1983 May; 31(5):661-70. PubMed ID: 6852982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines.
    Garnett MC; Baldwin RW
    Cancer Res; 1986 May; 46(5):2407-12. PubMed ID: 3457627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of action of an antibody-targetted drug-carrier conjugate.
    Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
    Anticancer Drug Des; 1985 Oct; 1(1):3-12. PubMed ID: 3879960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.
    Embleton MJ; Rowland GF; Simmonds RG; Jacobs E; Marsden CH; Baldwin RW
    Br J Cancer; 1983 Jan; 47(1):43-9. PubMed ID: 6571783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
    Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
    Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
    Affleck K; Embleton MJ
    Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
    Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
    NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience in the preparation and experimental use of immunocytostatics.
    Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
    Durrant LG; Garnett MC; Gallego J; Armitage NC; Ballantyne KC; Marksman RA; Hardcastle JD; Baldwin RW
    Br J Cancer; 1987 Dec; 56(6):722-6. PubMed ID: 3435698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
    Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
    Cancer Res; 1987 Feb; 47(4):1076-80. PubMed ID: 3802092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
    Pimm MV; Robins RA; Embleton MJ; Jacobs E; Markham AJ; Charleston A; Baldwin RW
    Br J Cancer; 1990 Apr; 61(4):508-13. PubMed ID: 2331436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targeting.
    Embleton MJ; Habib NA; Garnett MC; Wood C
    Int J Cancer; 1986 Dec; 38(6):821-7. PubMed ID: 3539823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity.
    Gallego J; Price MR; Baldwin RW
    Int J Cancer; 1984 Jun; 33(6):737-44. PubMed ID: 6376376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary.
    Pietersz GA; Cunningham Z; McKenzie IF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():43-9. PubMed ID: 3372005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human renal cancer by methotrexate linked to a monoclonal antibody.
    Singh M; Kralovec J; Mezei M; Ghose T
    J Urol; 1989 Feb; 141(2):428-31. PubMed ID: 2643730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of action of an MTX-HSA-MoAb conjugate.
    Fitzpatrick JJ; Garnett MC
    Anticancer Drug Des; 1995 Jan; 10(1):11-24. PubMed ID: 7695811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug/antibody conjugates. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
    Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
    Acta Paediatr Jpn; 1987 Aug; 29(4):566-8. PubMed ID: 3144892
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of methotrexate-alpha-alanine by carboxypeptidase A-monoclonal antibody conjugate.
    Haenseler E; Esswein A; Vitols KS; Montejano Y; Mueller BM; Reisfeld RA; Huennekens FM
    Biochemistry; 1992 Jan; 31(3):891-7. PubMed ID: 1731945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.